Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

New Technology to Treat Chronic Total Occlusion

Oct 18, 2015

Complete blockage of a coronary artery presents increased health risks and reduces quality of life

Delray Beach, Fla. (October 19, 2015— Delray Medical Center is offering a new minimally invasive alternative treatment option for Chronic Total Occlusion (CTO), a complete blockage of a coronary artery.

Historically, this condition was treated with heart bypass surgery or prescription drugs. Now, with Delray Medical Center’s new addition of the CrossBoss and Stingray Coronary CTO Crossing and Re-Entry devices, patients with chronic total occlusions have another option.

The new technology is designed to enable physicians to treat CTOs more successfully and efficiently using minimally invasive techniques. The CrossBoss and Stingray are the first devices of their kind to be used for coronary CTO crossing and re-entry.

“Chronic total occlusions used to have limited treatment options beyond medical management or surgery,” said Mark Bryan, CEO. “As one of the leading cardiac care providers in the area, we are proud to be able to offer our patients innovative technology and advanced treatment options.”

CTO, a complex form of coronary artery disease, affects the survival and quality of life of hundreds of thousands of people. Coronary artery disease is the most common type of heart disease, killing more than 370,000 people annually. Approximately every 34 seconds, one American has a coronary event, and approximately every minute, an American will die of one.

As part of the Tenet Florida Heart & Vascular Network, Delray Medical Center is a leading cardiac care provider for Palm Beach County, featuring an award-winning valve clinic, electrophysiology lab, open heart surgery program and chest pain center. The hospital’s highly skilled nursing and clinical staff, including cardiologists and cardiovascular surgeons, are performing some of the latest surgeries such as the TAVR procedure, MitraClip therapy and VAD implantations.

To learn more about chronic total occlusion and your treatment options, please visit www.delraymedicalctr.com/our-services/heart-vascular. For a free physician referral to a cardiologist near you, call (866) 358-4DOC (4362).

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.

Find a Doctor

Need a doctor for your care?